Boysen et al. found that p53 activation negatively regulates AXL expression via upregulation of miR-34a in CLL B-cells and it has been suggested that p53-inactivation stabilizes the AXL protein in CLL [68]. This evidence concerns the gene TP53 and B-cell chronic lymphocytic leukemia.